当前位置:主页 > 医学论文 > 呼吸病论文 >

COPD患者血清D-二聚体与基质金属蛋白酶-9测定的临床价值

发布时间:2018-03-17 14:39

  本文选题:慢性阻塞性肺疾病 切入点:D-二聚体 出处:《华中科技大学》2012年硕士论文 论文类型:学位论文


【摘要】:目的:探讨慢性阻塞性肺疾病(COPD)患者急性加重期治疗前后血清D-二聚体(D-D)、基质金属蛋白酶-9(MMP-9)及基质金属蛋白酶抑制剂-1(TIMP-1)水平的变化及意义。 方法:选取COPD急性加重期患者37例,正常对照组30例,用酶联免疫吸附(ELISA)方法检测其治疗前后血清中D-二聚体、MMP-9及TIMP-1的水平。结果:(1)COPD组治疗前血清D-二聚体、MMP-9及TIMP-1的水平均高于正常对照组;差别均具有统计学意义(P<0.01);COPD组治疗后D-二聚体、MMP-9及TIMP-1的水平也均高于正常对照组,差别均具有统计学意义(P<0.05),尤其是TIMP-1差异更为显著(P㩳0.01);COPD组治疗后D-二聚体、MMP-9及TIMP-1的水平明显低于治疗前,差异均有统计学意义(P㩳0.05)。(2)COPD组治疗前后,D-二聚体与MMP-9、D-二聚体与TIMP-1及MMP-9与TIMP-1均具有良好的正相关性,,且治疗前的相关系数大于治疗后。 结论:(1)COPD急性加重期患者血清D-二聚体、MMP-9及TIMP-1的浓度水平增高,体内可能存在高凝状态或血栓前状态,治疗后有一定程度改善;(2)COPD患者中D-二聚体与MMP-9有良好的正相关性,二者可作为COPD患者的疾病急时相反应因子;TIMP-1与MMP-9在治疗前后水平变化的一致程度有一定差异,影响二者表达水平的因素复杂多样,在COPD急性加重期患者中二者的失衡表现尤为突出。
[Abstract]:Objective: to investigate the changes and significance of serum D dimer D-DG, matrix metalloproteinase-9 (MMP-9) and matrix metalloproteinase inhibitor (MMP-1) in patients with chronic obstructive pulmonary disease (COPD) during acute exacerbation. Methods: 37 patients with acute exacerbation of COPD and 30 normal controls were selected. The serum levels of MMP-9 and TIMP-1 were detected by Elisa before and after treatment. Results the serum levels of MMP-9 and TIMP-1 in TIMP-1 group were higher than those in normal control group before and after treatment. The difference was statistically significant (P < 0.01). The levels of MMP-9 and TIMP-1 in the TIMP-1 group were higher than those in the normal control group (P < 0.05), especially in the TIMP-1 group. After treatment, the levels of MMP-9 and TIMP-1 were significantly lower in the 0. 01 TIMP-1 group than before treatment, and the difference was statistically significant (P < 0. 01). There were good positive correlations between D-dimer and MMP-9 D- dimer and TIMP-1, MMP-9 and TIMP-1 before and after treatment, and the correlation coefficient before and after treatment was higher than that before and after treatment. Conclusion the serum levels of MMP-9 and TIMP-1 in patients with acute exacerbation of TIMP-1 may be hypercoagulable or prethrombotic, and there is a good positive correlation between D- dimer and MMP-9 after treatment. The level of TIMP-1 and MMP-9 in patients with COPD before and after treatment were different, and the factors affecting their expression were complex and varied. In patients with acute exacerbation of COPD, the imbalance between the two is particularly prominent.
【学位授予单位】:华中科技大学
【学位级别】:硕士
【学位授予年份】:2012
【分类号】:R563.9

【参考文献】

相关期刊论文 前10条

1 李斌;佟丽;程兆忠;孙妮娜;;低分子肝素对COPD模型大鼠MMP-9及TIMP-1影响[J];青岛大学医学院学报;2009年05期

2 曾琼;炎症细胞、基质金属蛋白酶与肺气肿[J];国外医学.呼吸系统分册;2000年03期

3 葛夕洪;杨晶;徐锐;王永利;司同国;贺能树;;MMP-2、MMP-9、TIMP-1在血管成形术后再狭窄中的表达及其意义的实验研究[J];中国介入影像与治疗学;2008年03期

4 吕丽丽;朱述阳;姚红卫;夏春伟;刘平莉;李若然;;重度慢性阻塞性肺疾病急性加重期抗凝干预疗效观察[J];临床肺科杂志;2007年11期

5 程艳慧;何东初;;COPD发病机制分子生物学的最新研究进展[J];临床肺科杂志;2010年02期

6 孔英君;孙文学;霍建民;石玉枝;;慢性阻塞性肺疾病患者血清基质金属蛋白酶及其抑制因子与细胞黏附因子和血管内皮黏附因子的关系研究[J];中国实用内科杂志;2007年16期

7 周立红,刘泽霖;D-二聚体检测临床研究的近况[J];血栓与止血学;2002年03期

8 张天民;;基质金属蛋白酶与呼吸系统疾病关系的研究进展[J];医药导报;2007年03期

9 ;慢性阻塞性肺疾病诊治指南(2007年修订版)[J];中华结核和呼吸杂志;2007年01期

10 李红梅,崔德健,佟欣,马楠,高亚兵,崔雪梅,陆连荣,王德文,梁延杰;基质金属蛋白酶在大鼠慢性阻塞性肺疾病模型气道细胞外基质重塑中的作用[J];中华内科杂志;2002年06期



本文编号:1625193

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/huxijib/1625193.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户4a292***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com